Download DNB 2019 Dec 2019 Dec PHARMACOLOGY PAPER II Question Paper

Download Diplomate in National Board (DNB) 2019 Dec 2019 Dec PHARMACOLOGY PAPER II Previous Question Papers

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2019
PHARMACOLOGY
PAPER-II
Time: 3 hours
Max. Marks:100
Important Instructions:
Attempt all questions in order.
Each question carries 70 marks.
Read the question carefully and answer to the point neatly and legib/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer a// the parts of a single question together.
PHARM/D/19/34/II
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw tab/e/d/?agrams/?owcharts Wherever appropriate.
Write short notes on:
1.
2.
10.
Outline the pharmacological basis of treatment of opioid dependence.
a) Drug eluting coronary stents.
b) Intrauterine devices.
Discuss various roles of drugs in the management of cancer. Write details
about general toxicity to anticancer drugs, give suitable examples
wherever necessary.
a) Write briefly about medical management of Inflammatory Bowel
DiseaseUBD).
b) Give an outline of prevention of Graft-vs?Host Disease(GvHD) during
bone marrow transplantation.
Explain the mechanism of action of atypical antipsychotic drugs. Describe
the advantages and short comings of newer atypical antipsychotic drugs
over the older counterparts.
Give an outline of management of a patient with sputum positive
pulmonary tuberculosis who is now presented with anti?tubercular drug
induced liver injury.
Mention briefly about the recent advances of pharmacotherapy of
Parkinson?s disease(PD). Comment on therapeutic strategy to manage on
off phenomenon in PD. How would you manage drug induced
Parkinsonism?
Describe the pharmacotherapy of heart failure in patients with reduced
ejection fraction. Discuss the management of cardiogenic shock.
Give an outline of pharmacological management of postmenopausal
osteoporosis.
Give short description of Direct Acting Antivirals for chronic hepatitis} C
infections. Discuss the pharmacology and therapeutic status of dengue
vaccine.
***********
EX/I MINA 'I'ION [M L L.
10
5+5
4+6
5+5
4+3+3
1O
5+3+2
6+4
1O
6+4
P()SS/ZSSION/USE OF CELL PHONES OR AN Y S UCI I ELECTRONIC GADGETS IS NOT PERM! '17 'ED INSIDE THE